Negócios · 08/03/20011 min de leitura
Guidance for Industry on Levothyroxine Sodium; Questions and Answers; Availability
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Levothyroxine Sodium: Questions and Answers." The guidance is intended to answer questions concerning applications for orally administered levothyroxine sodium drug products.